Table 5.
Meta-analysis of the performance of biomarkers for SAP risk prediction in external validation.
| Number of Studies Included | ROC | SE | 95% CI | Q | I2 | Egger’s test | |
|---|---|---|---|---|---|---|---|
| NLR | 8 (35,55,56,74,84,86,87,90) | 0.803 | 0.0246 | 0.755 to 0.852 | 80.1075 | 91.26% | 0.0184 |
| CRP | 7 (34,35,42,50,56,69,73) | 0.800 | 0.0295 | 0.742 to 0.858 | 67.1831 | 91.07% | 0.2704 |
| Il-6 | 4 (69,76–78) | 0.808 | 0.0327 | 0.744 to 0.872 | 8.2440 | 63.61% | 0.1570 |
| Neutrophiles | 4 (35,56,73,82) | 0.787 | 0.0326 | 0.723 to 0.851 | 39.8361 | 92.47% | 0.0031 |
Abbreviations: CRP = C-Reactive Protein; IL-6 = Interleukin-6; I2 = I-squared; NLR = neutrophil-to-lymphocyte ratio; Q = Cochran’s Q; ROC = receiver operating characteristic.